{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:25:28Z","timestamp":1768944328139,"version":"3.49.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Clinical Research Hospital Program","award":["RCB 2017-002888-18"],"award-info":[{"award-number":["RCB 2017-002888-18"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>There are few data on the penetration of daptomycin into the cerebrospinal fluid (CSF) of patients with bacterial meningitis. This ancillary study of the AddaMap trial aimed to assess the CSF penetration of intravenous daptomycin in 13 patients with pneumococcal meningitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>Daptomycin was administered at 10\u2005mg\/kg\/day to 13 patients with pneumococcal meningitis admitted to the Dijon University Hospital. Blood and CSF samples were collected on days 3 and 8. The population pharmacokinetics of daptomycin in plasma and CSF were studied using a two-compartment model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A large inter-individual variability in plasma areas under the curve (median, 25\u201375-percentile), 7843\u2005h.mg\/L (6606\u20139264), plasma peak, 107.5\u2005mg\/L (81.4\u2013126.3) and trough 14\u2005mg\/L (7.6\u201319.3) concentrations and elimination half-lives, 8.8\u2005hours (7.9\u201310.8), was observed. In CSF, the maximum concentration was 0.88\u2005mg\/L (0.57\u20132.82), and the elimination half-life was 23.8\u2005hours (18.7\u201339.3). The AUC CSF\/plasma ratio was 2.20% (1.7\u20132.3). Daptomycin CSF penetration was significantly correlated with CSF levels of proteins and lactate. CSF concentrations, 0.67\u2005mg\/L (0.39\u20130.86), were above the MIC90 of pneumococci resistant to beta-lactam. Simulations showed that a loading dose could reduce the time required to reach a biologically active concentration in CSF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We conclude that daptomycin administered at a dose of 10\u2005mg\/kg\/day achieves CSF concentrations that may exert non-lytic anti-pneumococcal effects and demonstrate significant activity against highly resistant pneumococcal strains. These findings suggest that daptomycin could be considered as a valuable adjunctive therapy in the treatment of pneumococcal meningitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf474","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:15:49Z","timestamp":1765372549000},"source":"Crossref","is-referenced-by-count":0,"title":["Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis"],"prefix":"10.1093","volume":"81","author":[{"given":"Pascal","family":"Chavanet","sequence":"first","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, CHU Dijon , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-4606","authenticated-orcid":false,"given":"Alice","family":"Matheux","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Toxicologie, Plateforme de biologie Hospitalo-Universitaire , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2966-6346","authenticated-orcid":false,"given":"Thibault","family":"Sixt","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, CHU Dijon , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Barbet","sequence":"additional","affiliation":[{"name":"GIP Arronax, Nantes Universit\u00e9 , Nantes 44000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-995X","authenticated-orcid":false,"given":"Roland","family":"Nau","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, University Medicine G\u00f6ttingen, Georg-August-University G\u00f6ttingen , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Guerard","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Toxicologie, Plateforme de biologie Hospitalo-Universitaire , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Fournel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Bourgogne Europe, CHU Dijon Bourgogne, Centre d\u2019Investigation Clinique, module \u00e9pid\u00e9miologie clinique, INSERM, CIC1432 , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Mourvillier","sequence":"additional","affiliation":[{"name":"M\u00e9decine Intensive et r\u00e9animation polyvalente, CHU Reims , Reims 51100 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Blot","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, CHU Dijon , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-1032","authenticated-orcid":false,"given":"Lionel","family":"Piroth","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, CHU Dijon , Dijon 21000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2026012003080687300_dkaf474-B1","author":"ECDC"},{"key":"2026012003080687300_dkaf474-B2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in The Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026012003080687300_dkaf474-B3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cmi.2019.12.020","article-title":"Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort","volume":"26","author":"Tubiana","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2026012003080687300_dkaf474-B4","doi-asserted-by":"publisher","first-page":"121.e9","DOI":"10.1016\/j.cmi.2016.10.026","article-title":"Sex-based differences in adults with community-acquired bacterial meningitis: a prospective cohort study","volume":"23","author":"Dias","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2026012003080687300_dkaf474-B5","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1001\/jama.2022.20521","article-title":"Progress and challenges in bacterial meningitis: a review","volume":"328","author":"Hasbun","year":"2022","journal-title":"JAMA"},{"key":"2026012003080687300_dkaf474-B6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2026012003080687300_dkaf474-B7","doi-asserted-by":"publisher","first-page":"1102.e1","DOI":"10.1016\/j.cmi.2018.01.016","article-title":"Infectious meningitis and encephalitis in adults in Denmark: a prospective nationwide observational cohort study (DASGIB)","volume":"24","author":"Bodilsen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2026012003080687300_dkaf474-B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM199301073280104","article-title":"Acute bacterial meningitis in adults. A review of 493 episodes","volume":"328","author":"Durand","year":"1993","journal-title":"N Engl J Med"},{"key":"2026012003080687300_dkaf474-B9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3201\/eid2103.140634","article-title":"Risk factors for death from invasive pneumococcal disease, Europe, 2010","volume":"21","author":"Navarro-Torn\u00e9","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2026012003080687300_dkaf474-B10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(05)70288-X","article-title":"Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series","volume":"5","author":"Weisfelt","year":"2006","journal-title":"Lancet Neurol"},{"key":"2026012003080687300_dkaf474-B11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cid\/ciab477","article-title":"Pneumococcal meningitis in adults: a prospective nationwide cohort study over a 20-year period","volume":"74","author":"Koelman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026012003080687300_dkaf474-B12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/vaccines11081279","article-title":"Trends in pneumococcal and bacterial meningitis in Brazil from 2007 to 2019","volume":"11","author":"Parellada","year":"2023","journal-title":"Vaccines"},{"key":"2026012003080687300_dkaf474-B13","doi-asserted-by":"publisher","first-page":"e2424802","DOI":"10.1001\/jamanetworkopen.2024.24802","article-title":"Global case fatality of bacterial meningitis during an 80-year period: a systematic review and meta-analysis","volume":"7","author":"van Ettekoven","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026012003080687300_dkaf474-B14","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-019-09976-3","article-title":"Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis","volume":"10","author":"Lees","year":"2019","journal-title":"Nat Commun"},{"key":"2026012003080687300_dkaf474-B15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.inf.0000260253.22994.61","article-title":"High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease","volume":"26","author":"Carrol","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 3","key":"2026012003080687300_dkaf474-B16","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/S0929-693X(08)75494-0","article-title":"St\u00e9rilisations retard\u00e9es du liquide c\u00e9phalorachidien au cours des m\u00e9ningites \u00e0 pneumocoque de l\u2019enfant","volume":"15","author":"H\u00e9es","year":"2008","journal-title":"Arch Pediatr"},{"key":"2026012003080687300_dkaf474-B17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jneuroim.2005.05.014","article-title":"Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis","volume":"166","author":"Brandt","year":"2005","journal-title":"J Neuroimmunol"},{"key":"2026012003080687300_dkaf474-B18","author":"Chekrouni"},{"key":"2026012003080687300_dkaf474-B19","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.nbd.2024.106484","article-title":"Spatio-temporal brain invasion pattern of Streptococcus pneumoniae and dynamic changes in the cellular environment in bacteremia-derived meningitis","volume":"195","author":"Farmen","year":"2024","journal-title":"Neurobiol Dis"},{"key":"2026012003080687300_dkaf474-B20","doi-asserted-by":"publisher","first-page":"fcae131","DOI":"10.1093\/braincomms\/fcae131","article-title":"Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models","volume":"6","author":"Koning","year":"2024","journal-title":"Brain Commun"},{"key":"2026012003080687300_dkaf474-B21","doi-asserted-by":"publisher","first-page":"2387180","DOI":"10.1080\/21505594.2024.2387180","article-title":"Advances in the pathogenesis and treatment of pneumococcal meningitis","volume":"15","author":"Xu","year":"2024","journal-title":"Virulence"},{"key":"2026012003080687300_dkaf474-B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.15.1.95-110.2002","article-title":"Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis","volume":"15","author":"Nau","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"2026012003080687300_dkaf474-B23","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/CCM.0b013e3181a036c0","article-title":"Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis","volume":"37","author":"Spreer","year":"2009","journal-title":"Crit Care Med"},{"key":"2026012003080687300_dkaf474-B24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1471-4159.2004.02837.x","article-title":"Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone","volume":"91","author":"B\u00f6ttcher","year":"2004","journal-title":"J Neurochem"},{"key":"2026012003080687300_dkaf474-B25","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1128\/AAC.47.8.2649-2654.2003","article-title":"Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone","volume":"47","author":"Spreer","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B26","doi-asserted-by":"publisher","first-page":"106763","DOI":"10.1016\/j.ijantimicag.2023.106763","article-title":"Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria","volume":"61","author":"Jean","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2026012003080687300_dkaf474-B27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jgar.2021.03.007","article-title":"In vitro antimicrobial activity of daptomycin alone and in adjunction with either amoxicillin, cefotaxime or rifampicin against the main pathogens responsible for bacterial meningitis in adults","volume":"25","author":"Maldiney","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2026012003080687300_dkaf474-B28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1128\/AAC.45.6.1799-1802.2001","article-title":"Resistance studies with daptomycin","volume":"45","author":"Silverman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B29","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1128\/AAC.01000-06","article-title":"Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall","volume":"51","author":"Stucki","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1567202611666140520123424","article-title":"Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone","volume":"11","author":"Barichello","year":"2014","journal-title":"Curr Neurovasc Res"},{"key":"2026012003080687300_dkaf474-B31","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1093\/jac\/dku231","article-title":"Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis","volume":"69","author":"Vivas","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2026012003080687300_dkaf474-B32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2202-14-42","article-title":"Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis","volume":"14","author":"Barichello","year":"2013","journal-title":"BMC Neurosci"},{"key":"2026012003080687300_dkaf474-B33","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1128\/AAC.00674-12","article-title":"Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis","volume":"56","author":"Grandgirard","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B34","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1128\/AAC.00812-09","article-title":"Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis","volume":"54","author":"Grandgirard","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2334-9-50","article-title":"Daptomycin in experimental murine pneumococcal meningitis","volume":"9","author":"Mook-Kanamori","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2026012003080687300_dkaf474-B36","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1128\/AAC.00952-08","article-title":"Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone","volume":"53","author":"Egermann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B37","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/AAC.01014-06","article-title":"Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis","volume":"51","author":"Grandgirard","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12974-018-1272-8","article-title":"Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis","volume":"15","author":"Muri","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2026012003080687300_dkaf474-B39","doi-asserted-by":"publisher","first-page":"e00220-19","DOI":"10.1128\/AAC.00220-19","article-title":"Combining ceftriaxone with doxycycline and daptomycin reduces mortality, neuroinflammation, brain damage, and hearing loss in infant rat pneumococcal meningitis","volume":"63","author":"Muri","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jmii.2015.07.014","article-title":"Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules","volume":"50","author":"Vivas","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"2026012003080687300_dkaf474-B41","doi-asserted-by":"publisher","first-page":"e073032","DOI":"10.1136\/bmjopen-2023-073032","article-title":"Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study","volume":"13","author":"Chavanet","year":"2023","journal-title":"BMJ Open"},{"issue":"Suppl 3","key":"2026012003080687300_dkaf474-B42","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2026012003080687300_dkaf474-B43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.medmal.2019.03.009","article-title":"Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments","volume":"49","author":"Hoen","year":"2019","journal-title":"Med Mal Infect"},{"key":"2026012003080687300_dkaf474-B44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cpt1979253358","article-title":"Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine","volume":"25","author":"Sheiner","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"2026012003080687300_dkaf474-B45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12028-018-0657-y","article-title":"Daptomycin plasma and CSF levels in patients with healthcare-associated meningitis","volume":"31","author":"Piva","year":"2019","journal-title":"Neurocrit Care"},{"key":"2026012003080687300_dkaf474-B46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fmed.2015.00084","article-title":"Pharmacokinetics and dosimetry studies for optimization of pretargeted radioimmunotherapy in CEA-expressing advanced lung cancer patients","volume":"2","author":"Bodet-Milin","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"2026012003080687300_dkaf474-B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2049936119886465","article-title":"Efficacy and safety of daptomycin: systematic review and meta-analysis","volume":"6","author":"Rosanova","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"2026012003080687300_dkaf474-B48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/bcp.15671","article-title":"Comparison of the efficacy and safety of standard- and high-dose daptomycin: a systematic review and meta-analysis","volume":"89","author":"Samura","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"2026012003080687300_dkaf474-B49","doi-asserted-by":"publisher","first-page":"106770","DOI":"10.1016\/j.ijantimicag.2023.106770","article-title":"Daptomycin for the treatment of acute bacterial meningitis: a narrative review","volume":"61","author":"Jaber","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2026012003080687300_dkaf474-B50","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/AAC.01741-10","article-title":"Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections","volume":"55","author":"Kullar","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40262-020-00968-x","article-title":"Clinical pharmacokinetics of daptomycin","volume":"60","author":"Gregoire","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"2026012003080687300_dkaf474-B52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijantimicag.2018.03.008","article-title":"Population pharmacokinetics of daptomycin in critically ill patients","volume":"52","author":"Soraluce","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2026012003080687300_dkaf474-B53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/QCO.0000000000000418","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections","volume":"31","author":"Nau","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2026012003080687300_dkaf474-B54","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jac\/dkl007","article-title":"Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis","volume":"57","author":"Gerber","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2026012003080687300_dkaf474-B55","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012003080687300_dkaf474-B56","author":"ECDC"},{"key":"2026012003080687300_dkaf474-B57","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1128\/AAC.34.6.1220","article-title":"Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)","volume":"34","author":"Canepari","year":"1990","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/2\/dkaf474\/66468535\/dkaf474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/2\/dkaf474\/66468535\/dkaf474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:08:13Z","timestamp":1768896493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkaf474\/8430773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf474","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,19]]},"article-number":"dkaf474"}}